Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>
Background Health benefits of postpartum antiretroviral therapy (ART) for human immunodeficiency virus (HIV) positive women with high CD4+ T-counts have not been assessed in randomized trials. Methods Asymptomatic, HIV-positive, non-breastfeeding women with pre-ART CD4+ T-cell counts ≥ 400 cells/mm...
Saved in:
Similar Items
-
Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>
by: Judith S. Currier, et al.
Published: (2018) -
Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>
by: Judith S. Currier, et al.
Published: (2018) -
Ferroelectric and Dielectric Aging Effects of Fe<sup>3+</sup>/Nb <sup>5+</sup> hybrid-doped barium titanate ceramics
by: S. Prasertpalichatr, et al.
Published: (2018) -
<sup>1</sup>H, <sup>13</sup>C, <sup>15</sup>N backbone resonance assignment of Escherichia coli adenylate kinase
by: Brom J.A.
Published: (2023) -
Electroexcitation of the Δ<sup>+</sup>(1232) at low momentum transfer
by: A. Blomberg, et al.
Published: (2018)